News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 7, 2015

Cancer Diagnosis: No Insurance Coverage

Episodes in this series

EP. 1 Advice for Dealing With the Financial Burden

EP. 1 Advice for Dealing With the Financial Burden

EP. 2 Where to Look for Financial Help

EP. 2 Where to Look for Financial Help

EP. 3 Cancer Diagnosis: No Insurance Coverage

EP. 3 Cancer Diagnosis: No Insurance Coverage

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Between paying for treatment, managing a reduced income, and understanding insurance, the financial side of cancer can feel overwhelming.

Financial Planning Support for People and Families Impacted by Cancer

ByTriage Cancer®

October 16th 2025

CPAN begins the fourth quarter with a continued focus on its core mission: © stock.adobe.com.

2025 Quarter 3 – COA Patient Advocacy Network News Bulletin

By COA Patient Advocacy Network

October 2nd 2025

You don’t want to miss the upcoming CPAN Advocacy Chat, we hope you can join us!: © stock.adobe.com.

How PBMs Are Blocking Patient Access to Medication: A CPAN Advocacy Chat

By COA Patient Advocacy Network

October 2nd 2025

Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.

Making Cancer Clinical Trials More Accessible in Local Communities

ByKimberly Demirhan

July 30th 2025

Billions of dollars of cancer meds go to waste each year while many patients struggle to afford treatment: © stock.adobe.com.

Save Meds, Save Lives: How to Donate Your Extra Cancer Medication

ByDr. George Wang

July 21st 2025

Trending on CURE

Every FDA Oncology Approval From November 2025

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

What Patients Should Know About EGFR Mutated Lung Cancer Treatment

Finding Support When People Say Others Have It Worse

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

© 2025 MJH Life Sciences^®

All rights reserved.